Harbour Investments’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10
Closed -$8K 2783
2021
Q3
$8K Hold
10
﹤0.01% 2753
2021
Q2
$13K Hold
10
﹤0.01% 2572
2021
Q1
$11K Buy
+10
New +$13.2K ﹤0.01% 2541

Other funds holding CDLX

Harbour Investments's CDLX Position: Q4 2021 in Review

Harbour Investments sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 10 shares — an estimated $8K sold.

Harbour Investments first reported a position in CDLX in Q1 2021 and held it in 3 quarters. The position peaked at $13K in Q2 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

  • Harbour Investments reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 10 Cardlytics shares in Q4 2021, an estimated $8K.
  • Harbour Investments first reported a position in Cardlytics in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Cardlytics position peaked at $13K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.